smallmolecule inhibitor purchase targetmol wellesley hill usa include lipid metabolism compound library l2510 cb1 antagonist am251 t1915 am281 t2264 jd5037 t4453 otenabant t3530 tm3837 t8511 cb1in1 t5996 ferroptosis inducer erastin t1765 rsl3 t3646 ml210 t8375 fin56 t4066 cil56 t4309 pi3k inhibitor ly294002 t2008 mek inhibitor pd98059 t2623 cell line use study purchase american type culture collection atcc manassas va usa cell line authenticate accord short tandem repeat str profile tnbc cell line mdamb231 mdamb436 hcc38 hs578t luminal cell line mcf7 zr751 t47d her2enriched cell line skbr3 human embryonic kidney hek 293 cell grow dulbecco 's modify eagle medium dmem hyclone logan ut usa contain 25 mmoll glucose invitrogen carlsbad ca usa tnbc cell line hcc1937 luminal cell line bt474 cell grow roswell park memorial institute rpmi hyclone usa tnbc cell line bt549 cell grow rpmi hyclone usa contain insulin 10 μgml sigmaaldrich st. louis mo usa tnbc cell line bt20 cell grow eagle 's minimum essential medium mem gibco grand island ny usa cell line culture medium contain 10 fetal bovine serum fbs hyclone usa 1 penicillin invitrogen usa 1 streptomycin invitrogen usa human mammary epithelial cell hmec cell grow medium 171 invitrogen usa contain 5 mammary epithelial growth supplement meg invitrogen usa cell culture 37 °c 5 co. antibody purchase different source rabbit antiβactin 205361ap rabbit anticyclin d1 269391ap rabbit antip21 103551ap rabbit anticyclin b1 550041ap mouse antierk 671701ig rabbit antiakt 101762ap rabbit antiki67 273091ap purchase proteintech rosemont il usa rabbit anticb1 93815 rabbit antiscd1 2794 rabbit antiphosakt t308 13038 purchase cell signal technology boston usa mouse antiphoserk t202y204 sc136521 purchase santa cruz biotechnology dallas texas usa rabbit antifads2 pa548353 purchase invitrogen usa anti4hne ab46545 purchase abcam boston usa mdamb231 hcc1937 cell line stably overexpressing cb1 establish lentiviral transduction use pcdh plasmid system bioscience palo alto ca usa follow primer 5'cgggatccatgaagtcgatcctagatggcc3 forward 5'cggaattctcacagagcctcggcagacgtg3 reverse lentiviral construct human cb1 shrnas scd1 shrnas fads2 shrnas purchase genechem shanghai china lipofectamine 3000 reagent use transfection plasmid accord manufacturer 's instruction invitrogen usa shrna lentivirus infection lentivirus generate transfection 293 producer cell line lentiviral vector pack vector mix system bioscience usa lentivirus collect 48 h later use infect mdamb231 hcc1937 cell stable cell line select puromycin 3 μgml 48 h infection pool clone screen western blot wb anticb1 antiscd1 antifads2 respectively plasmid transfection cell seed 7090 confluent time transfection plasmid p3000 reagent dilute optimem invitrogen usa dilute plasmid mix dilute lipofectamine 3000. mixture incubate 15 min room temperature 2530 °c mixture add cell dish transfected cell collect 2448 h. cell viability assay breast cancer cell seed 96well plate 100 μl per well 5000 cellswell adhere overnight treat describe drug do 72 h dimethyl sulfoxide dmso use control anchoragedependent cell viability evaluate cell count kit8 cck8 kit accord manufacturer 's instruction dojindo laboratory mamoto ken japan colony formation assay stably transfected mdamb231 hcc1937 cell parental mdamb231 hcc1937 cancer cell plat six dish triplicate 2000 cell per well adhere overnight treat describe drug do 1014 day period drug treatment cell medium replace every 3 day contain describe drug subsequently colony fix 4 paraformaldehyde 25 min stain 0.2 crystal violet solution 30 min room temperature 2530 °c cell wash dry scan use hp scanjet 303 compound predominantly target receptor enzyme involve regulate lipid metabolism include cb1 acetylcoa carboxylase acc ampactivated protein kinase ampk fatty acid amide hydrolase faah hmgcoa reductase hmgcr sterolregulatory element bind protein srebps peroxisome proliferatorsactivated receptor ppar etc identify potential candidate synergy pair synergy index use estimate strength drug combination synergy index fa fafa synergy index fa fafa fraction cell inhibit drug describe fraction affect fa fa fa fa fa fa respectively represent inhibition rate lipid metabolism compound erastin rsl3 synergy lipid metabolism compound erastin synergy lipid metabolism compound rsl3 cell viability compare vehicletreated cell inhibitory effect single agent drug combination cell viability provide supplementary table 1 2. synergy index synergy index drug pair provide supplementary table 3 reflect strength combinational effect screen si 1 indicate antagonism si 1 indicate synergism size si value indicate effect drug combination drug screen perform 96well plate cell viability validate cck8 kit single combinational treatment 303 different lipid metabolism compound erastin rsl3 72 h accord manufacturer 's instruction dojindo laboratory japan potent combination define drug pair induce least 50 death tnbc cell line lipid metabolism compound correspond synergy index 1 synergy index 1. drug synergy assay synergy effect drug pair quantitative define choutalalay equation combinational index ci 1 indicate synergism ci 1 indicate antagonism 22. mdamb231 hcc1937 cell treat different concentration two single drug combinational treatment 72 h respectively cell viability validate cck8 kit accord manufacturer 's instruction dojindo laboratory japan mdamb231 hcc1937 cell seed 96well plate cell line tnbc nontnbc ~13 cell line 4000 cell per well cell viability assay conduct cck8 kit combinational treatment cb1 antagonist ferroptosis inducer erastin rsl3 ml210 fin56 cil56 72 h accord manufacturer 's instruction dojindo laboratory japan cell death rescue experiment effect various cell death pathway inhibitor calibrate cell line do effect ferroptosis inhibitor ferrostatin1 gsh deferoxamine cell death inhibitor use inhibit apoptosis zvadfmk necrosis necrostatin1 autophagy 3methyladenine indicate concentration 1 h treatment combination therapy mdamb231 hcc1937 cancer cell 1 × 10 cell culture sixwell dish adhere overnight treat rimonabant erastin rsl3 single treatment combination rimonabant erastin rimonabant rsl3 48 h. cell cycle analysis cell fix 75 ethanol 18 h 4 °c wash phosphate buffer saline pb incubate rnase 0.2 mgml pb propidium iodide add cell suspension sample analyze facs calibur flow cytometer becton dickinson franklin lake nj usa c11bodipy dye 10 μm use lipid ro stain accord manufacturer 's instruction d3861 thermo fisher scientific waltham usa positive control cumene hydroperoxide short stably transfected parental mdamb231 hcc1937 cancer cell collect treat rimonabant erastin rsl3 single treatment combination rimonabant erastin rimonabant rsl3 2 day 10 μm c11bodipycontaining medium 1 h lipid ro level determine flow cytometry analysis facs canto ii bd bioscience level gsh measure accord intracellular gsh detection assay kit abcam usa mdamb231 hcc1937 cell 1 × 10 treat rimonabant erastin rsl3 single treatment combination rimonabant erastin rimonabant rsl3 lysed gsh assay buffer gsh level measure accord manufacturer 's instruction colorimetric signal measure absorbance 405 nm use microplate reader molecular device sunnyvale ca usa gsh concentration calculate use standard curve protein quantification perform use pierce bca protein assay kit thermo fisher scientific usa describe manufacturer 's guideline value normalize total protein quantity per lysate sample result express mean ± sd fold change relative untreated control mdamb231 hcc1937 cell 1 × 10 cell culture sixwell dish adhere overnight treat compound 48 h. subsequently cell culture medium remove 2 ml dilute 25 μm carboxyhdcfda 88593074 invitrogen usa add sixwell plate follow incubation 37 °c 30 min cell gently wash three time warm pb tertbutyl hydroperoxide tbhp add positive control well ro level determine flow cytometry analysis use 488 nm excitation wavelength 525 nm emission wavelength facs canto ii bd bioscience relative mda concentration cell tumor lysates assess use lipid peroxidation mda assay kit ab118970 abcam accord manufacturer 's instruction assay measure mda reaction thiobarbituric acid tba generate mdatba adduct sample mdatba adduct quantify colorimetrically od 532 nm lipid peroxidation 4hne assay kit abcam ab238538 use evaluate concentration 4hne accord manufacturer 's protocol generation mdamb231 hcc1937 erastinrsl3resistance cell line parental cell culture 6 cm dish adhere overnight treat erastin 10 μm rsl3 1 μm 72 h. survive attach cell trypsinized wash pb recultured drugcontained medium drug concentration increase 25 treat every 2 week half maximal inhibitory concentration ic drugtolerant cell approximately ten time larger parental cell total rna isolate extract use trizol reagent accord manufacturer 's instruction invitrogen usa mdamb231 hcc1937 cancer cell pelleted wash 1 × pb trizol reagent 1 ml add sample lysate pipetted homogenize mixture follow incubation room temperature 2530 °c 5 min chloroform 200 μl add mixture incubate room temperature 2530 °c 23 min sample centrifuge 12,000 × g 4 °c 15 min afterwards transfer 400 μl colorless upper aqueous phase new ep tube isopropanol 400 μl add sample incubate room temperature 2530 °c 10 min sample centrifuge 12,000 × g 4 °c 10 min supernatant slowly pour wash 1 ml 75 ethanol prepare diethyl pyrocarbonate depc water supernatant discard dry 40 μl depc water add dissolve rna store 70 °c minimum 2 μg total rna reverse transcribe first strand cdna oligo dt primer use moloney murine leukemia virus reverse transcriptase promega madison wi usa qpcr perform triplicate 20 μl reaction mixture contain 10 μl sybr premix ex taq master mix 2× takara shigaken japan 0.5 mm primer 10 ng cdna relative expression level target calculate use comparative ct method βactin use internal control normalize sample difference animal study approve institutional animal care committee beijing institute biotechnology nude mouse purchase vital river laboratory animal technology beijing china house specific pathogen free spf animal facility tumor xenograft 5 × 10 mdamb231 hcc1937 cell mdamb231 cell stably transfected shnc shcb1 0.1 ml pb inject subcutaneously dorsal flank 6weekold female nude mouse mouse treat consecutively tumor size measure indicate time use caliper tumor volume estimate accord follow formula volume longest diameter × shortest diameter2 tumor reach volume ~100 mm mouse randomly divide group intraperitoneally inject drug every 2 day equivalent volume saline inject control animal mouse weigh tumor volume measure every 4 day tumor growth inhibition tgi utilize determine inhibitory strength drug treatment tumor growth tgi vc vtvc v 100 vc vt median volume control treat group end study respectively v median volume control start study experiment terminate maximum tumor size reach ~1.5 cm diameter euthanasia perform deep anesthesia alleviate suffer tumor isolate animal weigh sample minimum 3 μg total rna oligo dt select use dynabeads mrna purification kit invitrogen usa sequence library generate use nebnext03 ultratm rna library prep kit illumina03 neb ipswich usa follow manufacturer 's recommendation index code add attribute sequence briefly mrna purify total rna use polyt oligoattached magnetic bead doublestranded cdna synthesize endrepaired ligate illumina adapter size select agarose gel ~250 bp pcr amplify cdna library sequence illumina hiseq 6000 sequence platform berrygenomics beijing china gene expression level transcript estimate number read per kilobase exon model per million map read rpkm use uniquely map read exonic region gene consider significantly differentially express expression differ two sample fold change 2 pvalue 0.05 calculate cufflink rnaseq data available gene expression omnibus geo